Eventful exhibition Analysis of Pharmaceutical Marketing.docVIP

 PAGE \* MERGEFORMAT 10 Eventful exhibition Analysis of Pharmaceutical Marketing 2006 is bound to the pharmaceutical industry’s troubles, in March of medicine major political, continuous large-scale price cuts on many occasions, tired 0TC market storm after another of the prescription drug market, a chain reaction of the Qiqihar incident, followed by the Xinfu. At the same time, conflict, a loss, and explore and become a true portrayal of troubled times for several consecutive years of pharmaceutical marketing exhibition in 2006, has also become a focus of attention, the eyes of many concerns with this, many thought and exploration of the intersection with this. August 28, from Zhejiang Pharmaceutical Co., Ltd. CONBA hosted the first ‘the value of the integration vendors’ grand opening of the summit forum. Prior to this, CONBA has been active in domestic major media forum topics (such as participation in China’s drug stores to organize ‘super-terminal’ Forum), the lead industry in the first (as its Chief Marketing Consultant, Mr. Zhu Kuang Shan initiated ‘third terminal’ concept, the latter by the ‘Medical Economic News’, ‘the twenty-first century, pharmacies’ and other professional media on a national level), full participation of association with Chinese characteristics ‘big bag will be’ (two consecutive). All these will make this a national leader in both qualification based brands, but also the strength in the industry to promote a high-profile new model of pharmaceutical marketing. And in November, has successfully held two of the ‘big bag will be’ (central figure in Wang Yongping, Liu Yi, etc.), will usher in ‘the third’ test. ‘Big package will be’ how to solve the general agent of the quantity and quality problems? Supplier whether or not to manage contractor and how to level from a legal contract regulate major contractors and suppliers, ‘parcel business’ relationship? This will be the third largest package will be left to the industry suspense. In 2